| Bioactivity | CEP-8983 is a PARP-1 and PARP-2 inhibitor (IC50: 20 and 6 nM). CEP-8983 is an effective chemosensitizing agent, and can sensitize chemotherapy-resistant cell lines and subcutaneous xenografts to Temozolomide (HY-17364) and Camptothecin (HY-16560)[1]. |
| Target | 20 and 6 nM (PARP-1/2). |
| Name | CEP-8983 |
| CAS | 374071-46-2 |
| Formula | C18H14N2O3 |
| Molar Mass | 306.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Miknyoczki S, et al. The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity. Mol Cancer Ther. 2007 Aug;6(8):2290-302. |
CEP-8983
CAS: 374071-46-2 F: C18H14N2O3 W: 306.32
CEP-8983 is a PARP-1 and PARP-2 inhibitor (IC50: 20 and 6 nM). CEP-8983 is an effective chemosensitizing agent, and can
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.